½ÃÀ庸°í¼­
»óǰÄÚµå
1372875

¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø(2018-2028³â) : Á¦Ç° À¯Çüº°, ¸ñÀûº°, ºÎÀ§º°, ¿ëµµº°, À¯Åë ä³Îº°, »ç¾÷ ºÎ¹®º°, Áö¿ªº°, °æÀï

Wearable Medical Devices Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2018-2028 Segmented By Product Type, By Type, By Purpose, By Site, By Application, By Distribution Channel, By Business Segment, By Region & Competition

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 172 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀº 2022³â 246¾ï 4,000¸¸ ´Þ·¯ÀÇ °¡Ä¡¸¦ ´Þ¼ºÇϰí 2028³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR)ÀÌ 15.63%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¾î °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

¿þ¾î·¯ºí ÀÇ·á±â±â¿¡´Â °³ÀÎÀÌ Æí¾ÈÇÏ°Ô Âø¿ëÇÏ¿© °Ç°­ÀÇ ´Ù¾çÇÑ Ãø¸éÀ» ¸ð´ÏÅ͸µÇϰí ÃßÀûÇÒ ¼ö ÀÖ´Â ´Ù¾çÇÑ °Ç°­ °ü¸® ±â¼úÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ ±â±âµéÀº ºñħ½ÀÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ¼¾¼­, ¿¬°á ¹× µ¥ÀÌÅÍ ºÐ¼® ±â´ÉÀ» ÅëÇÕÇÏ¿© ÀûÀýÇÑ °Ç°­ Á¤º¸¸¦ ¼öÁýÇÏ°í ºÐ¼®ÇÕ´Ï´Ù. ¿þ¾î·¯ºí ±â±â´Â ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú Çǵå¹éÀ» Á¦°øÇÏ¿© °³ÀÎ, °£º´ÀÎ ¹× ÀÇ·á Àü¹®°¡°¡ °Ç°­°ú º¹Áö¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¿þ¾î·¯ºí ±â±âÀÇ ÀϹÝÀûÀÎ Ä«Å×°í¸®¿¡´Â ÇÇÆ®´Ï½º Æ®·¡Ä¿, ½º¸¶Æ®¿öÄ¡, ½É¹Ú¼ö ¸ð´ÏÅÍ, Ç÷´ç ¸ð´ÏÅÍ, Ç÷¾Ð ¸ð´ÏÅÍ µîÀÌ ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí µð¹ÙÀ̽º´Â °Ç°­ µ¥ÀÌÅ͸¦ Àü¼ÛÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó ÀÎÁö ¹× ±âºÐÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ¿© Á¤½Å°Ç°­ °ü¸®¸¦ Á¦°øÇÏ°í °³Àκ° ¸ÂÃãÇü °³ÀÔÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±âÀÇ ÀαⰡ ³ô¾ÆÁö´Â °ÍÀº ÀÌ·¯ÇÑ ¿ëµµ ¹× ±âŸ À¯»çÇÑ ¿ëµµ ¶§¹®ÀÔ´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ¿øÈ°ÇÑ µ¥ÀÌÅÍ Àü¼ÛÀ» À§ÇÑ ÀÎÅÍ³Ý ¿¬°á·Î ´õ¿í °­È­µÈ ½Ç¿ëÀûÀÌ°í Æí¸®ÇÑ ±â¼ú µµ±¸·Î ÀÛ¿ëÇÕ´Ï´Ù. ÀÌ ±â±âµéÀº »ç¸Á·ü Áõ°¡ÀÇ ¿øÀÎÀÌ µÇ´Â ¸¸¼º ÁúȯÀ» °ü¸®Çϱâ À§ÇØ ´Ù¾çÇÑ ÀÇ·á ±â°ü¿¡¼­ ¼±È£Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡µéÀº ¿ø°ÝÀ¸·Î ȯÀÚ¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ°í °³Àκ° ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ ÁÖ¿ä ÀåÁ¡Àº ½º¸¶Æ® ¼¾¼­¸¦ ÅëÇÕÇÏ¿© ½É¹Ú¼ö, Ç÷¾Ð, ü¿Â°ú °°Àº Áß¿äÇÑ »ý¸®Àû ¸Å°³ º¯¼ö¸¦ ÃøÁ¤ÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. È÷¾î·¯ºí, ÀÎÁ¦½ºÅÍºí µî ´Ù¾çÇÑ ÀÇ·á¿ë »ç¹°ÀÎÅͳÝ(IoT) ±â±â Áß ¿þ¾î·¯ºí ÀÇ·á ±â¼úÀÌ °¡Àå Àαâ ÀÖ´Â ¼±ÅÃÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2024-2028³â
½ÃÀå ±Ô¸ð 2022³â 246¾ï 4,000¸¸ ´Þ·¯
2028³â ½ÃÀå ±Ô¸ð 593¾ï 4,000¸¸ ´Þ·¯
CAGR 2023-2028³â 15.63%
±Þ¼ºÀå ºÎ¹® Áø´Ü ±â±â
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

¸¸¼ºÁúȯÀÇ Áõ°¡

ºñ°¨¿°¼º ÁúȯÀ̶ó°íµµ ºÒ¸®´Â ¸¸¼º ÁúȯÀº ÀϹÝÀûÀ¸·Î °¨¿°¼º ÁúȯÀÌ ¾Æ´Ï¶ó °Ç°­¿¡ ÇØ·Î¿î ½À°üÀ̳ª ÇൿÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â Áúº´À̳ª »óŸ¦ ¸»ÇÕ´Ï´Ù. ¸¸¼º ÁúȯÀº Àå±âÀûÀÎ °Ç°­ ¹®Á¦·Î À̾îÁú ¼ö ÀÖÀ¸¸ç, ´ë±Ô¸ð Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ¹üÁÖ¿¡ ¼ÓÇÏ´Â ÁúȯÀÇ ¿¹·Î´Â ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ¸¸¼º Æó Áúȯ, ´Ù¾çÇÑ ÇüÅÂÀÇ ¾Ï µîÀÌ ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¸¸¼ºÁúȯÀº Àü ¼¼°è »ç¸Á¿øÀÎÀÇ 74%¿¡ À°¹ÚÇϸç, ´ã¹è »ç¿ë, ºÒ°ÇÀüÇÑ ½Ä½À°ü, ¿îµ¿ ºÎÁ·, °úµµÇÑ À½ÁÖ µîÀÇ À§Çè¿äÀÎÀÌ ±× Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× ¿ø°ÝÀÇ·á ¼­ºñ½º ÀÌ¿ë Áõ°¡

¿ø°ÝÀÇ·á´Â Åë½Å ±â¼úÀ» ÀÌ¿ëÇØ ¿ø°ÝÁö³ª º´¿ø ¿ÜÀÇ Àå¼Ò¿¡¼­ Á¦°øµÇ´Â ÀÇ·á ¼­ºñ½º¸¦ Æ÷°ýÇÕ´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº ¿ø°Ý ÀÇ·áÀÇ ÇÑ ¿ä¼Ò·Î, ¿ø°ÝÁö¿¡¼­ ȯÀÚ¿Í »óÈ£ÀÛ¿ëÇÏ´Â ±â¼úÀ» »ç¿ëÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º¿Í ±â¼úÀº COVID-19 »çÅ ÀÌÈÄ ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀÚ°¡ »ó´çÈ÷ ¸¹´Ù´Â Á¡À» °¨¾ÈÇÒ ¶§, ¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ Ã¤ÅÃÀº ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ¸¸¼º Áúȯ ȯÀÚÀÇ ¿ø°Ý ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô Çϰí, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ȯÀÚÀÇ µ¥ÀÌÅÍ¿¡ ½Ç½Ã°£À¸·Î Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ÇØÁÝ´Ï´Ù. À̸¦ ÅëÇØ °Ç°­ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí, Àû½Ã¿¡ °³ÀÔÇϰí, ¿ø°Ý ÁøÂûÀ» ½±°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀº ºÒÇÊ¿äÇÑ º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÃÖ¼ÒÈ­Çϱ⠶§¹®¿¡ °Åµ¿ÀÌ ºÒÆíÇϰųª ÀæÀº ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ »ç¶÷µé¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

GluCare.Health(¾Æ¶ø¿¡¹Ì¸®Æ®)´Â ´ç´¢º´ ¼¾ÅÍ ¹× µðÁöÅÐ Ä¡·áÁ¦ ȸ»ç·Î, ÇͺñÆ®(Fitbit)¿Í °°Àº Áö¼ÓÀû Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ¿¬°áµÈ üÁ߰踦 Ȱ¿ëÇØ ȯÀÚ µ¥ÀÌÅ͸¦ ÃøÁ¤ÇÏ°í ¼öÁýÇÕ´Ï´Ù. ¶ÇÇÑ, Çʿ信 µû¶ó ÀÇ·á Àü¹®°¡¸¦ ÁöÁ¤ÇÏ¿© ȯÀÚ¿Í ¿ø°ÝÀ¸·Î ¿¬¶ôÀ» ÁÖ°í¹Þ½À´Ï´Ù. ¶ÇÇÑ, Àü´ã ÄɾîÆÀÀÌ Ç÷´ç ¼öÄ¡, ½É¹Ú¼ö, ¼ö¸é ÆÐÅÏ µî ȯÀÚÀÇ °Ç°­ µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇϰí, µ¿½Ã¿¡ ¾à¹° °ü¸®µµ Çϰí ÀÖ½À´Ï´Ù.

°Ç°­ µ¥ÀÌÅÍ ÃßÀû¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

°³ÀÎµé »çÀÌ¿¡¼­ °Ç°­ ½À°ü¿¡ ´ëÇÑ Á¤º¸¸¦ ±â·ÏÇϰí ÃßÀûÇÏ´Â °Í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °³ÀÎ ÀÎÆ÷¸Åƽ½º(Personal Informatics) ¿îµ¿Àº À̵¿ °Å¸®, Ä®·Î¸® ¼·Ãë·® µî ÀÏ»ó Ȱµ¿À» ½±°Ô ÃßÀûÇÒ ¼ö ÀÖ´Â ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀÇ µµÀÔ°ú ÇÔ²² Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ ½À°üÀº µ¥ÀÌÅÍ Àú³Î¸µ, ¶óÀÌÇÁ Æ®·¡Å·, °Ç°­ Á¤·®È­¶ó°íµµ ºÒ¸³´Ï´Ù. °¡¼Óµµ°è¿Í ¼¾¼­¸¦ žÀçÇØ ÀÚµ¿À¸·Î µ¥ÀÌÅ͸¦ ¼öÁýÇÏ´Â ¿þ¾î·¯ºí ´Ü¸»±â¸¦ °³¹ßÇÏ´Â ±â¾÷ÀÌ ´Ã¾î³²¿¡ µû¶ó »ç¿ëÀÚ´Â ¼öµ¿À¸·Î Á¤º¸¸¦ ÀÔ·ÂÇØ¾ß ÇÏ´Â ºÎ´ã¿¡¼­ ¹þ¾î³¯ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç÷Áß »ê¼Ò ³óµµ, È£Èí¼ö, ½É¹Ú¼ö, ¿­À¯¼Ó, °¥¹Ù´Ð ÇǺΠ¹ÝÀÀ, ÇǺΠ¿Âµµ µîÀ» ¸ð´ÏÅ͸µÇÏ´Â ¿þ¾î·¯ºí ±â±âµéµµ ¼Ó¼Ó µîÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó °Ç°­ µ¥ÀÌÅÍ ÃßÀû¿¡ ´ëÇÑ °ü½ÉÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

¼ÒºñÀÚµéÀº ÇöÀç ¿þ¾î·¯ºí ±â±â, ½º¸¶Æ®Æù ¾ÖÇø®ÄÉÀÌ¼Ç ¹× ±âŸ Ä¿³ØÆ¼µå µð¹ÙÀ̽º¸¦ ÅëÇØ °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ¼ö¸é °³¼±, Ä®·Î¸® °è»ê, üÁß °¨·® ¹× ÇÇÆ®´Ï½º ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â °ÍÀº ½¬¿î ÀÏÀÌ ¾Æ´Õ´Ï´Ù. ÇÏÁö¸¸ ÀÌ·¸°Ô Æí¸®Çϰí Áï°¢ÀûÀÎ °Ç°­ Á¤º¸ Á¢±ÙÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ÇコÄÉ¾î ºÐ¾ßÀÇ ¼ÒºñÀÚ Åµµ¿Í ±â´ëÄ¡°¡ Å©°Ô º¯È­Çϰí ÀÖ½À´Ï´Ù.

ÇöÀç ¼¾¼­ ±â¼úÀÇ ¹ßÀüÀ¸·Î »ý¸®Àû ½ÅÈ£¸¦ ÀÚµ¿À¸·Î ÃßÀûÇÒ ¼ö ÀÖ´Â Á¦Ç° °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ÇöÀç ´Ù¾çÇÑ »ý¸®Àû ±â´ÉÀ» ¿øÈ°ÇÏ°Ô Æ÷ÂøÇÒ ¼ö ÀÖ´Â ³ª³ë ½ºÄÉÀÏ ½ºÆ®·¹½º ¼¾¼­, ³»ÀåÇü ¼¾½Ì Ĩ, ±¤ÇÐ ¹ÙÀÌ¿À¼¾¼­, ÀüÀÚ ¹ÙÀÌ¿À¼¾¼­ ¹× ±âŸ ±â¼úµéÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ±Ã±ØÀûÀ¸·Î µ¥ÀÌÅÍ Ä¸Ã³´Â ȯ°æ ³»¿¡ ³»ÀåµÈ ÀåÄ¡¿Í ¼¾¼­·Î È®ÀåµÇ¾î ¿þ¾î·¯ºí ±â±â´Â ´õ ÀÌ»ó ¾µ¸ð¾ø°Ô µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, °í¼Ó ºñµð¿À¸¦ ÅëÇØ »ç¶÷ ¾ó±¼ÀÇ Ç÷·ù¸¦ ½Ã°¢È­Çϰí À̸¦ ¸Æ¹Ú¼ö·Î º¯È¯ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´Ü±âÀûÀ¸·Î ¿þ¾î·¯ºí ±â±â´Â À¯¿¬ÇÑ ÀüÀÚÁ¦Ç°ÀÌ ³»ÀåµÈ º¸¼®À̳ª Á¢Âø½Ä ÆÐÄ¡¿Í °°Àº ÇüÅ·ΠµðÀÚÀ뵃 °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. °³ÀÎ °Ç°­ µ¥ÀÌÅÍ ÃßÀûÀº µ¥ÀÌÅ͸¦ ÇØ¼®Çϰí, °æ°í¸¦ ¹ß·ÉÇϰí, ¼³¸í°ú Á¦¾ÈÀ» Á¦°øÇϵµ·Ï ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ´Â Áö´ÉÇü Á¶¾ð°ú ÄÚĪ ¼ÒÇÁÆ®¿þ¾î·Î ´õ¿í °­È­µÉ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ°ú Àåºñ´Â ¿îµ¿ ´É·Â°ú ½Åü ´É·ÂÀ» ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ÀüÀÚ ¹ÙÀÌ¿À ¼¾¼­´Â ¶¡ ¼ÓÀÇ Á¥»ê ¼öÄ¡¸¦ °¨ÁöÇÒ ¼ö ÀÖ¾î ¿îµ¿¼±¼öµéÀÌ ÈÆ·ÃÀ» °³¼±Çϰí Çø±â¼º ´ë»ç È¿À²À» ³ôÀÏ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

24½Ã°£ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

¾É¾ÆÀÖ´Â »ýȰ½À°üÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °íÇ÷¾Ð, ´ç´¢º´°ú °°Àº Áúº´ÀÇ À¯º´·üÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ Áúº´Àº Ç÷¾Ð, Ç÷´ç µî »ý¸®Àû ¸Å°³º¯¼ö¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇØ¾ß ÇÕ´Ï´Ù. µû¶ó¼­ ÀÇ·á µ¥ÀÌÅÍ¿Í ÈÞ´ë¿ë ±â±â¸¦ ÅëÇÕÇÏ¿© Àǻ簡 ½Ç½Ã°£À¸·Î ¾×¼¼½ºÇÏ°í ¿À·ù¸¦ ÁÙÀÌ°í »ê¾÷ ¼ö¿ä¸¦ ÃËÁøÇϱâ À§ÇØ ÀÇ·á µ¥ÀÌÅ͸¦ ÅëÇÕÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñ°¨¿°¼º ÁúȯÀÇ ¹ßº´·ü Áõ°¡¿¡ µû¸¥ »ç¸Á·ü Áõ°¡´Â ½É°¢ÇÑ ¹®Á¦À̸ç, ¿ø°Ý ¸ð´ÏÅ͸µ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í »ç¸Á·ü Áõ°¡´Â °³Àΰú Á¤ºÎ ±â°ü ¸ðµÎ¿¡°Ô ½É°¢ÇÑ ¹®Á¦ÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀڴ ȯÀÚÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» Æ÷ÇÔÇÑ °³Àκ° ¸ÂÃã Ä¡·á¿¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ´ëºÎºÐ 24½Ã°£ Âø¿ëÇÒ ¼ö Àֱ⠶§¹®¿¡ 24½Ã°£ 365ÀÏ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó ¿þ¾î·¯ºí ±â±â¿¡ ´ëÇÑ ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ±â¼ú ¹ßÀü°ú ½º¸¶Æ®Æù°úÀÇ ¿¬°á¼º µî ¸Å·ÂÀûÀÎ Á¦Ç° ±â´ÉÀÌ ÀÇ·á¿ë ¿þ¾î·¯ºíÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â±âµéÀº ÅëÁõ °ü¸®, ½ÉÀå ºÎÁ¤¸Æ, õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD) µî ´Ù¾çÇÑ °Ç°­ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, »ý¸íÀ» À§ÇùÇÒ ¼ö ÀÖ´Â ½ÉÀå ÁúȯÀ» °¡Áø »ç¶÷µéÀº ¿þ¾î·¯ºí ½ÉÀüµµ(ECG) ÀåÄ¡¸¦ »ç¿ëÇÏ¿© ½É¹Ú¼ö¸¦ ¸ð´ÏÅ͸µÇÏ°í ºÎÁ¤¸ÆÀ» °¨ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ¼û°¡»Ý, ÈäÅë ¹× ±âŸ ¿ì·ÁµÇ´Â Áõ»ó°ú °°Àº À̺¥Æ®¸¦ ±â·ÏÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â·Ï ÈÄ¿¡´Â ÇǺΠ¿Âµµ, Ç÷Áß »ê¼Ò ³óµµ, ½É¹Ú¼ö µî »ýü ÆÄ¶ó¹ÌÅ͸¦ ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ¿¹·Î´Â ÅëÁõ °ü¸®¿ë ¿þ¾î·¯ºí ±â±â°¡ Àִµ¥, ÀÇ·á ¾÷°è¿¡¼­ ÁøÅëÁ¦¸¦ Åõ¿©Çϰųª °æÇÇÀû Àü±â ½Å°æ ÀÚ±ØÀ» Á¦°øÇÏ´Â µ¥ ÀÚÁÖ »ç¿ëµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå °úÁ¦

½ÅÈï±¹¿¡¼­ÀÇ ÀÎ½Ä ºÎÁ·

Àú°³¹ß Áö¿ª°ú ½ÅÈï ½ÃÀå ÁֹεéÀÇ ÀÌÇØ ºÎÁ·Àº ÇâÈÄ ¸î ³â µ¿¾È ¿þ¾î·¯ºí ÀÇ·á±â±â ¼¼°è ½ÃÀå¿¡ Å« ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ±³À° ¹× ÀÇ·á ÀÚ¿ø¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑÀûÀÎ À̵é Áö¿ª¿¡¼­´Â ¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ Ã¤Åðú ¼ö¿ë¿¡ Àå¾Ö°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½º¸¶Æ®Æù ¹× ±âŸ ÷´Ü ±â¼úÀÇ °¡¿ë¼º°ú °¡°ÝÀÌ Á¦ÇѵǾî ÀÖ¾î À̵é Áö¿ª¿¡¼­ ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå È®´ë¿¡ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À庮À» ±Øº¹Çϱâ À§Çؼ­´Â Áö¸®Àû À§Ä¡³ª »çȸ°æÁ¦Àû ÁöÀ§¿¡ °ü°è¾øÀÌ ¸ðµç °³Àο¡°Ô ¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ ÀÌÁ¡ÀÌ Àü´ÞµÉ ¼ö ÀÖµµ·Ï Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç°ú Çù·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.

»óȯÁ¦µµÀÇ ºÎÁ·

ÀÇ·á Áø´Ü ¹× Ä¡·á ºñ¿ëÀÇ »ó½Â°ú ÇÔ²² ÀÇ·á ¼­ºñ½º µµÀÔ¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Â °ÍÀº ¹Ù·Î »óȯ ½Ã½ºÅÛÀÇ ºÎÁ·ÀÔ´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß°ú Àû½Ã °³ÀÔÀ» ¹æÇØÇÏ¿© ÀÇ·áºñ ÁöÃâÀ» ÁÙÀÌ´Â µ¥ ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù. ÇÇÆ®´Ï½º Æ®·¡Ä¿, ½º¸¶Æ®¿öÄ¡, ¼Õ¸ñ¹êµå, Çìµå±â¾î µî ¿þ¾î·¯ºí ÀÇ·á±â±â´Â Ȱµ¿ ÃßÀû, ÀÏ»óÀûÀÎ ¸ð´ÏÅ͸µ, Ȱ·Â¡ÈÄ µ¥ÀÌÅÍ ¼öÁý¿¡ »ç¿ëµÇÁö¸¸, ÇöÀç º¸Çè Àû¿ëÀ» ¹ÞÁö ¸øÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ±â±â´Â ÁÖ·Î °¡Ã³ºÐ ¼ÒµæÀÌ ³ôÀº °³ÀÎÀÌ »ç¿ëÇÒ ¼ö ÀÖ¾î Àü¹ÝÀûÀÎ ¼ºÀå ÀáÀç·ÂÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.

Àν¶¸° ÆßÇÁ¿Í °°Àº ¼¾¼­/Ĩ°ú °°Àº ƯÁ¤ Á¦Ç°Àº ȯÀÚÀÇ Ã¼³»¿¡ ÀÌ½ÄµÇ¾î ¸¸¼ºÁúȯ °ü¸®¸¦ À§ÇØ ÀÏÁ¤ÇÑ °£°ÝÀ¸·Î ¾à¹°À» Åõ¿©ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°µéÀº ¹Ì±¹ ¹× À¯·´ ±â°üÀ¸·ÎºÎÅÍ »óȯÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª »óȯÀ» ¹ÞÀ¸·Á¸é ±¤¹üÀ§ÇÑ ¹®¼­È­ ¹× °úÇÐÀû µ¥ÀÌÅÍ Áö¿øÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ

ÀΰøÁö´É ºÐ¾ß ±â¼úÀÇ ¹ßÀü

ÇコÄÉ¾î »ê¾÷ÀÇ µ¥ÀÌÅÍ ¾çÀÌ ±ÞÁõÇÏ°í º¹ÀâÇØÁö¸é¼­ ¿þ¾î·¯ºí ÀÇ·á±â±â¿¡ ƯȭµÈ ½ÇÇö °¡´ÉÇÑ ÀΰøÁö´É ¼Ö·ç¼Ç °³¹ß¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ¿¬±¸¿Í °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃÖ÷´Ü ¹ßÀüÀº AIÀÇ ÈûÀ» Ȱ¿ëÇÏ¿© ¿ø°Ý ¸ð´ÏÅ͸µ°ú ȯÀÚ Ä¡·á¸¦ °­È­ÇÔÀ¸·Î½á ÀÇ·á¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°íÀÚ ÇÕ´Ï´Ù. ¸ð¹ÙÀÏ Ç÷§ÆûÀÇ È®»ê°ú ÀçÅà ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó AI ±â¹Ý ¿þ¾î·¯ºí ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡´Â ÀΰøÁö´É ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú ÇÔ²² ¿¹Ãø ±â°£ µ¿¾È ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÇ ºñ¾àÀûÀÎ ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¾÷°è°¡ °è¼Ó ÁøÈ­Çϰí Çõ½ÅÇÏ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ Áö´ÉÇü ±â±â´Â ÀÇ·á ¼­ºñ½º Á¦°øÀ» º¯È­½Ã۰í, ȯÀÚ °á°ú¸¦ °³¼±Çϸç, ÀÇ·á Á¢±Ù ¹æ½ÄÀ» º¯È­½Ãų ¼ö Àִ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.

Á¦Ç°Çõ½Å

ÀÌ·¯ÇÑ ±â¼úÀÌ ÀÇ·á±â±â¿¡ µµÀԵǰí ÅëÇյǸ鼭 »ýü Àνİú °Ç°­ ¸ð´ÏÅ͸µÀÇ È¿À²¼ºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ¹ßÀüÀº Àû±ØÀûÀÎ °Ç°­ °ü¸®, Áúº´ÀÇ Á¶±â Áø´Ü ¹× ¿¹¹æ¿¡ Å« ±â´ë¸¦ ºÒ·¯ÀÏÀ¸Å°°í ±Ã±ØÀûÀ¸·Î ȯÀÚ °á°ú °³¼±À¸·Î À̾îÁú °ÍÀÔ´Ï´Ù. ±× °á°ú, Á¦Ç° Çõ½ÅÀÇ ¹°°áÀÌ Ä¿Áö¸é¼­ ¿¹Ãø ±â°£ µ¿¾È ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÇ ½ÃÀå Ç÷¹À̾°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¡Á¡ ´õ ¸¹Àº º´¿øÀÌ RFID ±â¹Ý ¼Ö·ç¼Ç°ú °°Àº µðÁöÅÐ ¼ö¼ú µµ±¸ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» äÅÃÇÏ¿© ¼ö¼ú µµ±¸ÀÇ Á¦¾î ¹× °ü¸®¸¦ ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¼ö¼ú ¼Óµµ¸¦ ³ôÀ̰í ÀûÀýÇÑ µµ±¸¸¦ »ç¿ëÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀü°ú º´¿øÀÇ ¿î¿µ È¿À²¼ºÀ» ¸ðµÎ Çâ»ó½Ãų ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

ºÎ¹®º° ÀλçÀÌÆ®

À¯Çüº° ÀλçÀÌÆ®

½ÃÀåÀº À¯Çüº°·Î Áø´Ü Àåºñ¿Í Ä¡·á Àåºñ·Î ±¸ºÐµË´Ï´Ù. Áø´Ü±â±â ºÐ¾ß°¡ ½ÃÀåÀ» Àå¾ÇÇϸç 2022³â ¸ÅÃâ¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áø´Ü ±â±â Áß ½Å°æ ¸ð´ÏÅ͸µ ºÐ¾ß´Â °°Àº ÇØ¿¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù. ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

Ä¡·á ±â±â ºÐ¾ß´Â Ä¡·á ±â±âÀÇ À¯ÀÔÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Áö´ÉÇü õ½Ä °ü¸® Á¦Ç°, ¿þ¾î·¯ºí ÅëÁõ ¿ÏÈ­ ÀåÄ¡, Àν¶¸° °ü¸® ÀåÄ¡¿Í °°Àº °­·ÂÇÑ Ä¡·á ±â±â ÆÄÀÌÇÁ¶óÀÎÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎÀ§º° ÀλçÀÌÆ®

ºÎÀ§º°·Î´Â ½ºÆ®·¦/Ŭ¸³/ÆÈÂî, ÇÚµåÇïµå, Çìµå¹êµå, ½Å¹ß ¼¾¼­, ±âŸ·Î ºÐ·ùµË´Ï´Ù. ½ºÆ®·¦/Ŭ¸³/ÆÈÂî ºÎ¹®Àº ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå¿¡¼­ ¾ÐµµÀûÀÎ °­¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, 2022³â¿¡ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç ¿¹Ãø ±â°£ µ¿¾È ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½º¸¶Æ®¿öÄ¡¿Í °°Àº ÷´Ü Á¦Ç°Àº À̵¿¼º, È£Èí¼ö, ¸Æ¹Ú¼ö µî ´Ù¾çÇÑ ¸Å°³º¯¼ö¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ±â´ÉÀ» Á¦°øÇϸç, ºí·çÅõ½º ¹× Ŭ¶ó¿ìµå ¿¬°áÀ» Ȱ¿ëÇÏ¿© ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

2014³â 3¿ù¿¡ Ãâ½ÃµÈ ¹ÙÀÌŻĿ³ØÆ®(Vital Connect)ÀÇ °Ç°­ ÆÐÄ¡·Î ´ëÇ¥µÇ´Â ¼Õ¸ñ Âø¿ëÇü Á¦Ç°ÀÇ ³î¶ó¿î ¹ßÀüÀº ½É¹Ú¼ö, ÇǺΠ¿Âµµ, °ÉÀ½ ¼ö µî ¿©·¯ ¸Å°³º¯¼ö ¸ð´ÏÅ͸µ¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ¶ÇÇÑ, »ï¼º°ú ¾ÖÇðú °°Àº ¾÷°è ¼±µÎÁÖÀÚµéÀº ¿þ¾î·¯ºí ÀÇ·á±â±â¿Í ¿øÈ°ÇÏ°Ô ÅëÇÕµÇ¾î µ¥ÀÌÅÍ ±â·Ï ¹× µðÁöÅÐ µð½ºÇ÷¹À̸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ¸ð¹ÙÀÏ ¾ÛÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ·¯ÇÑ »ç¿ëÀÚ Ä£È­ÀûÀÎ ¾ÛÀº ÀÏ»óÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ °ü½É°ú °ü½ÉÀ» ºÒ·¯ ÀÏÀ¸ÄÑ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

ºÏ¹Ì Áö¿ªÀº ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ¾ÏÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç¿Í ¸¸¼º Áúȯ¿¡ ´ëÇÑ ÀÏ»óÀûÀ̰í Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀº ¾Ï, ´ç´¢º´, ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Çö´ë½Ä ÀÇ·á ½Ã¼³ÀÇ °¡¿ë¼ºÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº Á¤ºÎÀÇ Àû±ØÀûÀÎ ³ë·Â°ú ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·áºñ Áõ°¡¿¡ ÈûÀÔ¾î ±Þ°ÝÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ¶ÇÇÑ ÀÇ·á ¿¬±¸¿Í ÀÇ·á ¼­ºñ½º °­È­¸¦ À§ÇÑ °Ç¼³ ¹× ÀÇ·á ÀÎÇÁ¶ó °³¹ß¿¡µµ Å« ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀº ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ Á¤ºÎÀÇ Àû±ØÀûÀΠȰµ¿, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·áºñ Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¿þ¾î·¯ºí ÀÇ·á±â±â ¼¼°è ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°(Ȱµ¿·® ¸ð´ÏÅÍ/Æ®·¡Ä¿, ½º¸¶Æ® ¿öÄ¡, ÆÐÄ¡, ½º¸¶Æ® ¿þ¾î)
    • À¯Çüº°(Áø´Ü ±â±â, Ä¡·á ±â±â)
    • ¸ñÀûº°(½É¹Ú¼ö, ½Åü Ȱµ¿, Ç÷Áß»ê¼ÒÆ÷È­µµ, Ç÷¾Ð, û°¢ º¸Á¶, ü¿Â, ÀÚ¼¼, ±âŸ Ȱµ¿)
    • ºÎÀ§º°(½ºÆ®·¦/Ŭ¸³/ÆÈÂî, ÇÚµåÇïµå, Çìµå¹êµå, ½´Áî ¼¾¼­, ±âŸ)
    • ¿ëµµº°(ÀÏ¹Ý °Ç°­ ¹× ÇÇÆ®´Ï½º, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ÀçÅà ÇコÄɾî)
    • À¯Åë ä³Îº°(¹«Á¡Æ÷Çü, Á¡Æ÷Çü)
    • ºñÁö´Ï½º ºÎ¹®º°(B2C, B2B)
    • Áö¿ªº°
    • ±â¾÷º°(2022³â)
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹Ì ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Çüº°
    • ¸ñÀûº°
    • »çÀÌÆ®º°
    • À¯Åë ä³Îº°
    • »ç¾÷ ºÎ¹®º°
    • ±¹°¡º°
  • ºÏ¹Ì ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦7Àå À¯·´ ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Çüº°
    • ¸ñÀûº°
    • »çÀÌÆ®º°
    • À¯Åë ä³Îº°
    • »ç¾÷ ºÎ¹®º°
    • ±¹°¡º°
  • À¯·´ ±¹°¡º° ºÐ¼®
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Çüº°
    • ¸ñÀûº°
    • »çÀÌÆ®º°
    • À¯Åë ä³Îº°
    • »ç¾÷ ºÎ¹®º°
    • ±¹°¡º°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦9Àå ³²¹Ì ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Çüº°
    • ¸ñÀûº°
    • »çÀÌÆ®º°
    • À¯Åë ä³Îº°
    • »ç¾÷ ºÎ¹®º°
    • ±¹°¡º°
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • À¯Çüº°
    • ¸ñÀûº°
    • »çÀÌÆ®º°
    • À¯Åë ä³Îº°
    • »ç¾÷ ºÎ¹®º°
    • ±¹°¡º°
  • MEA : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÃÖ±ÙÀÇ Àü°³
  • ÀμöÇÕº´
  • Á¦Ç° ¹ßÇ¥

Á¦13Àå ¿þ¾î·¯ºí ÀÇ·á±â±â ¼¼°è ½ÃÀå SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • ¾÷°è³» °æÀï
  • ½Å±Ô Âü¿© °¡´É¼º
  • °ø±Þ¾÷üÀÇ ´É·Â
  • °í°´ÀÇ ´É·Â
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °æÀï »óȲ

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Medtronic plc
    • Siemens AG
    • Bayer AG
    • Omron Corporation
    • Withings SAS
    • Fitbit Inc.
    • Intelesens Ltd
    • BioBeat Medical Ltd
    • Koninklinje Philips NV
    • Samsung Electronics Co. Ltd

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm 23.11.09

The Global Wearable Medical Devices Market has achieved a valuation of USD 24.64 Billion in 2022 and is poised for remarkable growth, with an anticipated Compound Annual Growth Rate (CAGR) of 15.63% through 2028. Wearable medical devices encompass a diverse array of healthcare technologies that individuals can comfortably wear to monitor and track various aspects of their health. These devices are designed for non-invasive and user-friendly use, incorporating sensors, connectivity features, and data analysis capabilities to collect and analyze pertinent health information. They offer real-time monitoring and feedback, empowering individuals, caregivers, and healthcare professionals to make informed decisions regarding health and well-being. Common categories of wearable devices encompass fitness trackers, smartwatches, heart rate monitors, glucose monitors, and blood pressure monitors.

Wearable devices not only transmit health data but also provide mental health care by monitoring cognition and mood in real-time, facilitating personalized interventions. The growing popularity of wearable devices can be attributed to these and other similar applications. Wearable medical devices serve as practical and convenient technological tools, further enhanced by internet connectivity for seamless data transmission. These devices are endorsed by various healthcare organizations for the management of chronic diseases, which have been on the rise, contributing to increased mortality rates. Healthcare professionals can remotely and continuously monitor patients, delivering personalized care.

The primary advantage of wearable medical devices lies in their integration of smart sensors, enabling the measurement and monitoring of crucial physiological parameters such as heart rate, blood pressure, and body temperature. Among various medical Internet of Things (IoT) devices like hearables or ingestibles, wearable medical technology has emerged as the most popular choice.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 24.64 Billion
Market Size 2028USD 59.34 Billion
CAGR 2023-202815.63%
Fastest Growing SegmentDiagnostic Devices
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Chronic Diseases

Chronic diseases, also referred to as non-communicable diseases, are disorders or conditions that are typically not caused by infections but rather by unhealthy habits or behaviors. They can lead to long-term health issues, necessitating extensive treatment. Examples of diseases falling under this category include cardiovascular diseases, diabetes, chronic lung ailments, and various forms of cancer. According to the World Health Organization (WHO), chronic diseases account for nearly 74% of global deaths, with risk factors such as tobacco use, unhealthy diets, physical inactivity, and excessive alcohol consumption contributing to their growth.

Wearable medical devices offer significant benefits to patients with chronic diseases by facilitating diagnosis, monitoring, and disease intensity control. These devices collect substantial amounts of data over time, enabling individuals and healthcare professionals to analyze trends and patterns. This valuable information provides insights into treatment effectiveness, triggers for symptom exacerbation, and the impact of lifestyle modifications. By comprehending these patterns, individuals can make well-informed decisions regarding their health management strategies. There has been a recent push by consumer wearable device companies to develop devices for comprehensive health monitoring. For example, Apple, Inc. (U.S.) has developed the Apple Watch Series 8, equipped with sensors that can detect abnormal heart rhythms and identify Atrial Fibrillation (AFib). With a 99.6% accuracy in sinus rhythm classification and precise identification of AFib, this watch has received clearance from the U.S. FDA.

Other watches and smart devices are also available to monitor patient vitals and track their health remotely, offering time and cost savings. Continuous glucose monitoring patches, blood pressure monitoring devices, and smart clothing are among the various wearable medical devices available. These factors, combined with healthcare providers' promotion of wearable medical devices, are expected to drive their increased usage and contribute to market growth.

Increasing Use of Remote Patient Monitoring and Telehealth Services

Telehealth encompasses healthcare services provided remotely or from locations outside of hospitals, utilizing telecommunication technologies. Remote patient monitoring, a component of telehealth, employs technologies to interact with patients from a distance. These services and technologies have experienced increased utilization since the onset of the COVID-19 pandemic. Given the considerable number of patients with chronic diseases, the adoption of wearable medical devices is expected to rise even further. Wearable medical devices facilitate remote monitoring of individuals with chronic conditions, enabling healthcare providers to access real-time patient data. This facilitates early detection of health issues, timely interventions, and remote consultations. Such capabilities are particularly valuable for individuals with limited mobility or those requiring frequent monitoring, as it minimizes the need for unnecessary hospital visits.

GluCare.Health (UAE), a diabetes center and digital therapeutics company, leverages continuous glucose monitoring systems like Fitbit and connected weighing scales to measure and collect patient data. They have appointed healthcare professionals to remotely connect with patients as needed. Additionally, a dedicated care team monitors patients' health data, including glucose levels, heart rate, and sleep patterns, while managing their medications.

Increasing Demand for Health Data Tracking

There has been a growing interest among individuals in recording and tracking information regarding their health habits. The personal informatics movement gained popularity with the introduction of mobile applications that facilitated the tracking of daily activities such as distance covered and calorie intake. This practice is also referred to as data journaling, life tracking, or health quantification. As more companies develop wearable devices equipped with accelerometers and sensors to automatically capture data, users are relieved of the burden of manually inputting information. Additionally, wearable devices that monitor blood oxygen levels, respiration rate, heart rate, heat flux, galvanic skin response, and skin temperature are being introduced by various companies. Consequently, the interest in health data tracking has surged.

Consumers now have the means to manage their health using wearable devices, smartphone applications, and other connected devices. However, achieving goals related to sleep improvement, calorie counting, weight loss, and fitness is not an easy task. Nevertheless, such convenient and immediate access to health information is reshaping consumer attitudes and expectations in the field of healthcare.

The focus is now on developing products that enable the automatic tracking of physiological signals, which can be realized through advancements in sensor technology. Nanoscale stress sensors, implantable sensing chips, optical biosensors, electronic biosensors, and other technologies are currently being developed to enable the seamless capture of various physiological functions. Ultimately, data capture will extend to devices and sensors embedded within our environment, rendering wearable devices obsolete. For instance, high-speed video can be used to visualize blood flow in a person's face, which can then be translated into pulse rate. In the short term, wearable devices will be designed in forms that resemble jewelry or adhesive patches, incorporating flexible electronics. The tracking of individual health data will be further enhanced by intelligent advisory and coaching software that can be customized to interpret data, provide alerts, and offer explanations and suggestions. These systems and devices will prove instrumental in optimizing athletic and physical performance. For instance, electronic biosensors can detect the level of lactic acid in sweat, enabling athletes to improve their training and enhance anaerobic metabolism efficiency.

Rising Demand for Round-The-Clock Monitoring

Due to sedentary lifestyles, the prevalence of diseases such as hypertension and diabetes is projected to rise in the forecast period. These diseases necessitate continuous monitoring of physiological parameters like blood pressure and blood sugar levels. This underscores the need for integrating healthcare data with portable devices, enabling real-time access for physicians, reducing errors, and driving industry demand. Additionally, the escalating mortality rates associated with the growing incidence of noncommunicable diseases are a significant concern, further fueling the demand for remote monitoring devices. These factors are expected to drive the market for wearable medical devices.

The increasing prevalence of chronic diseases and rising mortality rates are significant concerns for individuals and government organizations alike. Consequently, healthcare providers are placing greater emphasis on personalized care, including continuous patient monitoring. Wearable medical devices offer 24/7 monitoring capabilities, as many can be worn around the clock. As a result, the demand for wearable devices is expected to surge in the forecast period.

Moreover, technological advancements and appealing product features such as smartphone connectivity are driving the adoption of medical wearables. These devices are being developed to address various health issues, including pain management, heart arrhythmia, asthma, and COPD. For instance, individuals with potentially life-threatening heart conditions can use wearable electrocardiograph (ECG) devices to monitor heart rate and detect arrhythmias. These devices can record events such as shortness of breath, chest pains, and other concerning symptoms. Once recorded, the device measures vital parameters such as skin temperature, blood oxygen level, and heart rate. Another example includes wearable devices for pain management, often utilized in the medical industry to administer pain medication or provide transcutaneous electrical nerve stimulation.

Key Market Challenges

Lack of Awareness in Developing Countries

The lack of understanding among the populace in underdeveloped or developing regions could be a significant concern for the global wearable medical devices market in the coming years. In these locations, where access to education and healthcare resources may be limited, the adoption and acceptance of wearable medical devices may face obstacles. Moreover, the limited availability and affordability of smart phones and other advanced technologies further add to the challenges in expanding the wearable medical devices market in these regions. Overcoming these barriers will require innovative solutions and collaborations to ensure that the benefits of wearable medical devices reach all individuals, irrespective of their geographical location or socioeconomic status.

Non-Availability of Reimbursement

The lack of reimbursement facilities, combined with the rising cost of medical diagnosis and therapies, has a significant impact on the adoption of healthcare services. It hinders the reduction of healthcare expenditure by impeding the early detection of diseases and timely intervention. Wearable medical devices, such as fitness trackers, smartwatches, wristbands, and headgear, which are utilized for activity tracking, routine monitoring, and vital parameter data collection, currently do not receive reimbursement. Consequently, these devices are primarily accessible to individuals with higher disposable income, thereby limiting their overall growth potential.

Certain products, such as sensors/chips like insulin pumps, are embedded into a patient's body and administer drug dosages at fixed intervals for the management of chronic conditions. These products are eligible for reimbursement by agencies in the U.S. and Europe. However, obtaining reimbursement requires extensive documentation and the support of scientific data.

Key Market Trends

Technological Advancements in The Field Of Artificial Intelligence

The rapid growth in the volume and complexity of data within the healthcare industry has spurred extensive research and exploration into developing feasible artificial intelligence solutions specifically tailored for wearable medical devices. These cutting-edge advancements aim to revolutionize healthcare by harnessing the power of AI to enhance remote monitoring and patient care. With the increasing popularity of mobile platforms and a growing preference for remote monitoring in the comfort of one's home, the demand for AI-powered wearable medical devices is skyrocketing. This surge in demand, coupled with the continuous technological advancements in the field of artificial intelligence, presents lucrative opportunities for the exponential growth of the wearable medical devices market throughout the forecast period. As the industry continues to evolve and innovate, these intelligent devices are poised to transform healthcare delivery, improving patient outcomes and revolutionizing the way we approach medical treatments.

Product innovations

The introduction and integration of these technologies in medical devices have significantly enhanced their efficiency in vital identification and health monitoring. These innovative advancements hold great promise in proactive health management, early disease diagnosis, and prevention, ultimately leading to improved patient outcomes. As a result, the growing wave of product innovations presents lucrative opportunities for market players in the wearable medical devices market during the forecast period. Furthermore, an increasing number of hospitals are now adopting digital surgical instrument monitoring systems, such as RFID-based solutions, to optimize the control and management of surgical tools. By expediting surgical procedures and ensuring the availability of appropriate equipment, these technologies have the potential to enhance both patient safety and hospital operational efficiency.

Segmental Insights

Type Insights

Based on the type, the market is segmented into diagnostic devices and therapeutic devices. The diagnostic devices segment dominated the market and accounted for the largest share of revenue in 2022. Among diagnostic devices, the neuromonitoring segment was the largest in the same year. The growing prevalence of neurological disorders is a key factor driving the growth of this segment.

The therapeutic device segment is expected to experience the fastest CAGR throughout the forecast period due to the increasing influx of therapeutic devices. Additionally, a robust pipeline of therapeutic devices, including intelligent asthma management products, wearable pain reliever devices, and insulin management devices, is expected to support market growth.

Site Insights

Based on the site segment, the market is segmented into strap/clip/bracelet, handheld, headband, shoe sensors, and others. The strap/clip/bracelet segment has emerged as the dominant force in the wearable medical devices market, securing the largest revenue share in 2022 and projected to maintain its dominance throughout the forecast period. Advanced products like smartwatches offer the ability to monitor various parameters including mobility, respiratory rate, and pulse rate, leveraging Bluetooth and cloud connectivity to drive segment growth.

Significant advancements in wrist-worn products, exemplified by Vital Connect's Health patch introduced in March 2014, have revolutionized the monitoring of multiple parameters such as heart rate, skin temperature, and step count. Moreover, industry giants like Samsung and Apple have introduced mobile apps that seamlessly integrate with wearable medical instruments, enabling data recording and digital display. These user-friendly apps have garnered attention and interest in routine health monitoring, consequently fueling market growth.

Regional Insights

North America dominated the market in 2022 due to the increasing prevalence of diabetes, cardiovascular disorders, and cancer in the region. The presence of a well-established healthcare infrastructure and the need for routine and continuous monitoring of chronic diseases further contribute to the market growth. The wearable medical devices market is expected to expand throughout the forecast period, driven by the rising prevalence of cancer, diabetes, and cardiovascular diseases, as well as the availability of modern healthcare facilities.

In contrast, the Asia Pacific region experiences exponential growth, supported by favorable government initiatives, a growing elderly population, and increased healthcare expenditure. The region also presents significant opportunities for infrastructure development in construction and healthcare, aiming to enhance medical research and services. The wearable medical devices market is witnessing expansion in the Asia-Pacific region, driven by favorable government activities, an increasing senior population, and rising healthcare expenditures.

Key Market Players

  • Medtronic plc
  • Siemens AG
  • Bayer AG
  • Omron Corporation
  • Withings SAS
  • Fitbit Inc.
  • Intelesens Ltd
  • BioBeat Medical Ltd
  • Koninklinje Philips NV
  • Samsung Electronics Co. Ltd

Report Scope:

In this report, the Global Wearable Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wearable Medical Devices Market, By Product Type:

  • Activity Monitors/Trackers
  • Smartwatches
  • Patches
  • Smart Clothing

Wearable Medical Devices Market, By Type:

  • Diagnostic Devices
  • Therapeutic Devices

Wearable Medical Devices Market, By Purpose:

  • Heart rate
  • Physical Activities
  • Blood oxygen saturation
  • Blood Pressure
  • Hearing Aids
  • Body Temperature
  • Posture
  • Others

Wearable Medical Devices Market, By Site:

  • Strap/Clip/Bracelet
  • Handheld
  • Headband
  • Shoe Sensors
  • Others

Wearable Medical Devices Market, By Application:

  • General Health & Fitness
  • Remote Patient Monitoring
  • Home Healthcare

Wearable Medical Devices Market, By Distribution Channel:

  • Non-Store-Based
  • Store-Based

Wearable Medical Devices Market, By Business Segment:

  • B2C
  • B2B

Wearable Medical Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Wearable Medical Devices Market.

Available Customizations:

  • Global Wearable Medical Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wearable Medical Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Activity Monitors/Trackers, Smartwatches, Patches, Smart Clothing)
    • 5.2.2. By Type (Diagnostic Devices and Therapeutic Devices)
    • 5.2.3. By Purpose (Heart rate, Physical Activities, Blood oxygen saturation, Blood Pressure, Hearing Aids, Body Temperature, Posture, Others)
    • 5.2.4. By Site (Strap/Clip/Bracelet, Handheld, Headband, Shoe Sensors, Others)
    • 5.2.5. By Application (General Health & Fitness, Remote Patient Monitoring, Home Healthcare)
    • 5.2.6. By Distribution Channel (Non-Store-Based and Store-Based)
    • 5.2.7. By Business Segment (B2C and B2B)
    • 5.2.8. By Region
    • 5.2.9. By Company (2022)
  • 5.3. Market Map

6. North America Wearable Medical Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Type
    • 6.2.3. By Purpose
    • 6.2.4. By Site
    • 6.2.5. By Distribution Channel
    • 6.2.6. By Business Segment
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Wearable Medical Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Purpose
        • 6.3.1.2.4. By Site
        • 6.3.1.2.5. By Distribution Channel
        • 6.3.1.2.6. By Business Segment
    • 6.3.2. Canada Wearable Medical Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Purpose
        • 6.3.2.2.4. By Site
        • 6.3.2.2.5. By Distribution Channel
        • 6.3.2.2.6. By Business Segment
    • 6.3.3. Mexico Wearable Medical Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Purpose
        • 6.3.3.2.4. By Site
        • 6.3.3.2.5. By Distribution Channel
        • 6.3.3.2.6. By Business Segment

7. Europe Wearable Medical Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Type
    • 7.2.3. By Purpose
    • 7.2.4. By Site
    • 7.2.5. By Distribution Channel
    • 7.2.6. By Business Segment
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Wearable Medical Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Purpose
        • 7.3.1.2.4. By Site
        • 7.3.1.2.5. By Distribution Channel
        • 7.3.1.2.6. By Business Segment
    • 7.3.2. United Kingdom Wearable Medical Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Purpose
        • 7.3.2.2.4. By Site
        • 7.3.2.2.5. By Distribution Channel
        • 7.3.2.2.6. By Business Segment
    • 7.3.3. Italy Wearable Medical Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Purpose
        • 7.3.3.2.4. By Site
        • 7.3.3.2.5. By Distribution Channel
        • 7.3.3.2.6. By Business Segment
    • 7.3.4. France Wearable Medical Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Purpose
        • 7.3.4.2.4. By Site
        • 7.3.4.2.5. By Distribution Channel
        • 7.3.4.2.6. By Business Segment
    • 7.3.5. Spain Wearable Medical Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Purpose
        • 7.3.5.2.4. By Site
        • 7.3.5.2.5. By Distribution Channel
        • 7.3.5.2.6. By Business Segment

8. Asia-Pacific Wearable Medical Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Type
    • 8.2.3. By Purpose
    • 8.2.4. By Site
    • 8.2.5. By Distribution Channel
    • 8.2.6. By Business Segment
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Wearable Medical Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Purpose
        • 8.3.1.2.4. By Site
        • 8.3.1.2.5. By Distribution Channel
        • 8.3.1.2.6. By Business Segment
    • 8.3.2. India Wearable Medical Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Purpose
        • 8.3.2.2.4. By Site
        • 8.3.2.2.5. By Distribution Channel
        • 8.3.2.2.6. By Business Segment
    • 8.3.3. Japan Wearable Medical Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Purpose
        • 8.3.3.2.4. By Site
        • 8.3.3.2.5. By Distribution Channel
        • 8.3.3.2.6. By Business Segment
    • 8.3.4. South Korea Wearable Medical Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Purpose
        • 8.3.4.2.4. By Site
        • 8.3.4.2.5. By Distribution Channel
        • 8.3.4.2.6. By Business Segment
    • 8.3.5. Australia Wearable Medical Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Purpose
        • 8.3.5.2.4. By Site
        • 8.3.5.2.5. By Distribution Channel
        • 8.3.5.2.6. By Business Segment

9. South America Wearable Medical Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Type
    • 9.2.3. By Purpose
    • 9.2.4. By Site
    • 9.2.5. By Distribution Channel
    • 9.2.6. By Business Segment
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Wearable Medical Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Purpose
        • 9.3.1.2.4. By Site
        • 9.3.1.2.5. By Distribution Channel
        • 9.3.1.2.6. By Business Segment
    • 9.3.2. Argentina Wearable Medical Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Purpose
        • 9.3.2.2.4. By Site
        • 9.3.2.2.5. By Distribution Channel
        • 9.3.2.2.6. By Business Segment
    • 9.3.3. Colombia Wearable Medical Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Purpose
        • 9.3.3.2.4. By Site
        • 9.3.3.2.5. By Distribution Channel
        • 9.3.3.2.6. By Business Segment

10. Middle East and Africa Wearable Medical Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Type
    • 10.2.3. By Purpose
    • 10.2.4. By Site
    • 10.2.5. By Distribution Channel
    • 10.2.6. By Business Segment
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Wearable Medical Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Purpose
        • 10.3.1.2.4. By Site
        • 10.3.1.2.5. By Distribution Channel
        • 10.3.1.2.6. By Business Segment
    • 10.3.2. Saudi Arabia Wearable Medical Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Purpose
        • 10.3.2.2.4. By Site
        • 10.3.2.2.5. By Distribution Channel
        • 10.3.2.2.6. By Business Segment
    • 10.3.3. UAE Wearable Medical Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Purpose
        • 10.3.3.2.4. By Site
        • 10.3.3.2.5. By Distribution Channel
        • 10.3.3.2.6. By Business Segment

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Wearable Medical Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Medtronic plc
    • 15.5.2. Siemens AG
    • 15.5.3. Bayer AG
    • 15.5.4. Omron Corporation
    • 15.5.5. Withings SAS
    • 15.5.6. Fitbit Inc.
    • 15.5.7. Intelesens Ltd
    • 15.5.8. BioBeat Medical Ltd
    • 15.5.9. Koninklinje Philips NV
    • 15.5.10. Samsung Electronics Co. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦